Bindarit is primarily used in research for its anti-inflammatory properties. It selectively inhibits the production of monocyte chemoattractant proteins, such as MCP-1, MCP-2, and MCP-3, which play key roles in recruiting immune cells to sites of inflammation. This makes bindarit a compound of interest in studying inflammatory diseases including arthritis, lupus nephritis, and atherosclerosis. It has also been investigated for its potential to reduce fibrosis in conditions like liver and kidney disease. Due to its ability to modulate immune responses without broad immunosuppression, bindarit serves as a valuable tool in exploring targeted anti-inflammatory therapies.